Stuzenz, they would surely test for this as part of the safety regime inherent in the clinical trials (2A/2B)? There was some mention of filtering out candidates that suffered from bleeding as it could exasperate this condition to some extent? But I dont know enough about the details. Overall it certainly passed the trail and was found to have NO show-stopping side effects. Do your own research, std disclaimers blah.
The competition and their side effects, page-24
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.0¢ |
Change
0.035(10.8%) |
Mkt cap ! $82.30M | |||
| Open | High | Low | Value | Volume |
| 34.0¢ | 36.5¢ | 34.0¢ | $659.8K | 1.878M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 60655 | 36.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 159133 | 7 |
View Market Depth
| Last trade - 10.39am 25/11/2024 (20 minute delay) ? |
| PAR (ASX) Chart |
